[1]
Albuquerque, R. de C.R. de, Vieira, C.L., Santiago, I.C. de A., Nascimento, A. do, Chança, R.D., Tura, B.R., Correia, M.G. and Barufaldi, L.A. 2024. BTK and BCL-2 Inhibitors in the First-Line Treatment of Chronic Lymphocytic Leukemia in High-Risk Patients: Systematic Review and Network Meta-Analysis. Revista Brasileira de Cancerologia. 70, 2 (Mar. 2024), e–014501. DOI:https://doi.org/10.32635/2176-9745.RBC.2024v70n2.4501.